Developing and Delivering Appropriate HIV Medicines for Children

Today (Feb. 24) the Medicines Patent Pool (MPP) announced a new licensing agreement with pharmaceutical company Merck & Co. that will allow generic manufacturers to produce low-cost pediatric versions of Merck's HIV medication, raltegravir. Read a blog from MPP's Executive Director Greg Perry on the importance of these agreements. Keep reading

Swaziland Adolescents Work Toward an HIV-free Generation

During most of his teen years, Mbongeni Dlamini wondered if he would ever ask a girl to go out with him. His normal adolescent fears were compounded by the fact that he is HIV-positive. Today, through his involvement with a psychosocial support group, Mbongen has the confidence to envision a girlfriend — and eventually a wife and family. Keep reading